Clinical Pharmacology Details


Nandrolone Decanonate


View Drug Forms

Indications & Dose:

Osteoporosis in postmenopausal women (but not recommended)



Adult (female): 50 mg every 3 weeks.


Anemia of renal insufficiency



Adult: Usually: Nandrolone decanoate: 25-100mg i.m. every 3 weeks.


Children: 5-15mg every 3 weeks. 

Contraindications:

Male patients with prostate or breast cancer, hypercalcemia in females with breast cancer, nephrosis, nephrotic phase of nephritis, enhancement of physical appearance or athletic performance 

Side Effects:

Cautions:

Precautions:

Elderly, children. cardiac disease or risk factors for atherosclerosis, renal disease, hepatic disease, seizure disorder, migraine headache, diabetes 

Interaction:

Drugs


Antidiabetic agents: Enhanced hypoglycemic effects


Cyclosporine: Increased cyclosporine concentrations, potential for toxicity


HMG-CoA reductuse inhibitors (lovastatin, pravastatin): Myositis risk increased


Oral anticoagulants:Enhanced hypoprothrombinemic response


Tacrolimus: Increased tacrolimus concentrations, potential for toxicity 

Warnings:

Adverse Effects:

Lactations:

Use extreme caution in nursing mothers 

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

CNS: Choreiform movement, depression, excitation, habituation, insomnia


CV: Edema


EENT: Deepening of voice, hoarseness


GI: Cholestatic jaundice, diarrhea, hepatic necrosis, hepatocellular neoplasms, nausea, peliosis hepatis, vomiting


GU: Amenorrhea, clitoral hypertrophy, decreased breast size, decreased libido, testicular atrophy, vaginitis, virilization


METAB: Decreased glucose tolerance, decreased HDL cholesterol, increased LDL cholesterol, increased serum cholesterol, retention of sodium, chloride, water, potassium, phosphates, calcium


MS: Premature closure of epiphyses in children


SKIN: Acne, alopecia, flushing; hirsutism, rash, sweating 

Patient And Carer Advice: